drugset / Trial / NCT02373150

Safety, Tolerability and PK of Imeglimin in Japanese Volunteers

NCT02373150

Phase 1 Completed 48 enrolled Poxel SA
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess the pharmacokinetics of single and repeated doses of imeglimin in healthy Japanese subjects, and the safety and tolerability of single and repeated doses of imeglimin in healthy Japanese subjects.

Timeline

Start
2015-02
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Imeglimin Small molecule